Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 12.10% vs -7.67% in Mar 2025
Standalone Net Profit
YoY Growth in year ended Mar 2026 is 6.43% vs -14.16% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 11.50% vs -30.11% in Mar 2025
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
Compare Annual Results Of Amwill Health With
Figures in Cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
45.49
108.77
-63.28
-58.18%
Other Operating Income
0.00
0.00
0.00
Total Operating income
45.49
108.77
-63.28
-58.18%
Raw Material Cost
13.87
0.00
13.87
Purchase of Finished goods
0.00
93.71
-93.71
-100.00%
(Increase) / Decrease In Stocks
-0.28
1.41
-1.69
-119.86%
Employee Cost
8.41
2.91
5.50
189.00%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
10.50
6.63
3.87
58.37%
Total Expenditure (Excl Depreciation)
32.50
104.66
-72.16
-68.95%
Operating Profit (PBDIT) excl Other Income
12.99
4.11
8.88
216.06%
Other Income
2.92
3.84
-0.92
-23.96%
Operating Profit (PBDIT)
15.91
7.95
7.96
100.13%
Interest
0.00
1.96
-1.96
-100.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
15.91
5.99
9.92
165.61%
Depreciation
0.55
0.60
-0.05
-8.33%
Profit Before Tax
15.37
5.39
9.98
185.16%
Tax
3.94
1.36
2.58
189.71%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
11.42
4.03
7.39
183.37%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
11.42
4.03
7.39
183.37%
Equity Capital
20.00
13.05
6.95
53.26%
Face Value
10.00
1.00
0.00
Reserves
60.57
0.00
60.57
Earnings per share (EPS)
5.71
0.31
5.40
1,741.94%
Diluted Earnings per share
5.71
0.31
5.40
1,741.94%
Operating Profit Margin (Excl OI)
28.56%
3.78%
0.00
24.78%
Gross Profit Margin
34.97%
5.51%
0.00
29.46%
PAT Margin
25.10%
3.71%
0.00
21.39%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 45.49 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 12.10% vs -7.67% in Mar 2025
Annual - Standalone Net Profit
Standalone Net Profit 11.42 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 6.43% vs -14.16% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.99 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.50% vs -30.11% in Mar 2025
Annual - Interest
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.56%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has fallen from Mar 2025






